Science Explorer Back to mapMap
Institution · ARPE PACA

Most cited papers from ARPE PACA

What are the most cited papers from ARPE PACA?

The most cited paper from ARPE PACA is "The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey" (Heidi Jane Larson, Alexandre de Figueiredo, Xiahong Zhao et al., 2016), with 1,307 citations. Next come "First two autochthonous dengue virus infections in metropolitan France, September 2010" (529) and "The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue" (433).

Showing 50 of 59 papers. Every paper with more than 83 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey Heidi Jane Larson, Alexandre de Figueiredo, Xiahong Zhao et al. · EBioMedicine Open access 14 Sep 2016 1,307
2 First two autochthonous dengue virus infections in metropolitan France, September 2010 Guy La Ruche et al. · Eurosurveillance Open access 30 Sep 2010 529
3 The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue Jeremy Keith Ward, Caroline Alleaume, Patrick Peretti‐Watel et al. · Social Science & Medicine Open access 6 Oct 2020 433
4 Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward Daniel Wolfe, Patrizia Carrieri, Donald S. Shepard · The Lancet Jul 2010 421
5 Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020 Pierre Verger, Dimitri Scronias, Nicolás Dauby et al. · Eurosurveillance Open access 21 Jan 2021 411
6 Intimate partner violence among adolescents and young women: prevalence and associated factors in nine countries: a cross-sectional study Heidi Stöckl, Laura March, Christina Pallitto et al. · BMC Public Health Open access 24 Jul 2014 367
7 Vaccine Hesitancy: Clarifying a Theoretical Framework for an Ambiguous Notion Patrick Peretti‐Watel, Jeremy Keith Ward, William Small Schulz et al. · PLoS Currents Open access 2015 355
8 Variation of NO2 and NO concentrations between and within 36 European study areas: Results from the ESCAPE study Josef Cyrys et al. · Atmospheric Environment Open access 30 Aug 2012 351
9 Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France Pierre Verger, Lisa Fressard, Fanny Collange et al. · EBioMedicine Open access 23 Jun 2015 346
10 HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe Emilie Karafillakis, Clarissa Simas, Caitlin Jarrett et al. · Human Vaccines & Immunotherapeutics ReviewOpen access 11 Jan 2019 326
11 Yersinia pestis: the Natural History of Plague Riccardo Barbieri, Michel Signoli, Dominique Chevé et al. · Clinical Microbiology Reviews Open access 8 Dec 2020 257
12 Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance? Michaël Schwarzinger, Rémi Flicoteaux, Sébastien Cortarenoda et al. · PLoS ONE Open access 16 Apr 2010 255
13 Restoring confidence in vaccines in the COVID-19 era Pierre Verger, Ève Dubé · Expert Review of Vaccines Open access 17 Sep 2020 232
14 Underlying factors impacting vaccine hesitancy in high income countries: a review of qualitative studies Ève Dubé, Dominique Gagnon, Noni E. MacDonald et al. · Expert Review of Vaccines 25 Oct 2018 232
15 Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment Jacqueline Capeau, Vincent Bouteloup, Christine Katlama et al. · AIDS 16 Nov 2011 232
16 Covid‐19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level François Beck, Damien Léger, Lisa Fressard et al. · Journal of Sleep Research Open access 28 Jun 2020 188
17 Autochthonous case of dengue in France, October 2013 Elodie Marchand, Christine M. A. Prat, Charles Jeannin et al. · Eurosurveillance Open access 12 Dec 2013 177
18 Injecting misuse of buprenorphine among French drug users Yolande Obadia, V. Perrin, Isabelle Feroni et al. · Addiction Feb 2001 172
19 What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries Louisa J Degenhardt, Bradley M. Mathers, Andrea L. Wirtz et al. · International Journal of Drug Policy Open access 4 Sep 2013 169
20 Socio-economic characteristics, living conditions and diet quality are associated with food insecurity in France Aurélie Bocquier, Florent Vieux, Sandrine Lioret et al. · Public Health Nutrition Open access 7 Jan 2015 160
21 Viscoelastic behaviour of cellular solutions to the Kuramoto-Sivashinsky model U. Frisch, Zhen Su She, Olivier Thual · Journal of Fluid Mechanics Jul 1986 155
22 Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies Aurélie Bocquier, Jeremy Keith Ward, Jocelyn Raude et al. · Expert Review of Vaccines Review 15 Sep 2017 145
23 Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance Dominique Rey, Lisa Fressard, Sébastien Cortaredona et al. · Eurosurveillance Open access 26 Apr 2018 141
24 Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017 Clémentine Calba, Mathilde Guerbois-Galla, Florian Franke et al. · Eurosurveillance Open access 28 Sep 2017 141
25 Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe Hannah Fraser et al. · Journal of Hepatology Open access 8 Jan 2018 139
26 Vaccine Education of Medical Students: A Nationwide Cross-sectional Survey Solen Kernéis et al. · American Journal of Preventive Medicine 22 Feb 2017 135
27 Vector-borne transmission of Zika virus in Europe, southern France, August 2019 S. Giron et al. · Eurosurveillance Open access 7 Nov 2019 130
28 The French health pass holds lessons for mandatory COVID-19 vaccination Jeremy Keith Ward, Fátima Gauna, Amandine Gagneux‐Brunon et al. · Nature Medicine Open access 12 Jan 2022 127
29 The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study Perrine Roux, Patrizia Carrieri, Virgine Villes et al. · Addiction 5 Sep 2008 127
30 Lung Cancer Attributable to Indoor Radon Exposure in France: Impact of the Risk Models and Uncertainty Analysis Olivier Catelinois, Agnès Rogel, Dominique Laurier et al. · Environmental Health Perspectives Open access 30 May 2006 125
31 The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases Sébastien Cortaredona, Bruno Ventelou · BMC Medicine Open access Dec 2017 122
32 Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial Marc Bourlière et al. · ˜The œLancet. Gastroenterology & hepatology Open access 19 Jan 2017 121
33 Vaccine hesitancy and coercion: all eyes on France Jeremy Keith Ward, Patrick Peretti‐Watel, Aurélie Bocquier et al. · Nature Immunology Open access 2 Sep 2019 119
34 ‘I Think I Made The Right Decision … I Hope I'm Not Wrong’. Vaccine hesitancy, commitment and trust among parents of young children Patrick Peretti‐Watel, Jeremy Keith Ward, Chantal Vergélys et al. · Sociology of Health & Illness Open access 11 Apr 2019 117
35 Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial Collins C. Iwuji, Joanna Orne‐Gliemann, Frank C Tanser et al. · Trials Open access 2013 116
36 Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors Sylvie Boyer, Isabelle Clerc, Cécile-Renée Bonono et al. · Social Science & Medicine 9 Mar 2011 115
37 Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data Camélia Protopopescu, F. Raffi, Perrine Roux et al. · Journal of Antimicrobial Chemotherapy Open access 14 Jul 2009 109
38 Attitudes toward vaccination and the H1N1 vaccine: Poor people's unfounded fears or legitimate concerns of the elite? Patrick Peretti‐Watel, Jocelyn Raude, Luis Sagaon‐Teyssier et al. · Social Science & Medicine Mar 2014 108
39 Vaccine hesitancy in health-care providers in Western countries: a narrative review Pierre Verger, Élisabeth Botelho-Nevers, Amanda Garrison et al. · Expert Review of Vaccines ReviewOpen access 22 Mar 2022 107
40 Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France Rose Wilson, Anna Zaytseva, Aurélie Bocquier et al. · Vaccine Open access 3 Dec 2019 107
41 Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte dʼIvoire Jean‐Paul Moatti, Joanne Prudhomme, Djénéba Coulibaly Traore et al. · AIDS Jul 2003 105
42 Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults Fidéline Collin, Xavier Duval, Vincent Le Moing et al. · AIDS Open access 15 May 2009 105
43 Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed? Laëtitia Huiart, Anne‐Déborah Bouhnik, Dominique Rey et al. · European Journal of Cancer Open access 29 Mar 2012 102
44 Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public? Michaël Schwarzinger, Pierre Verger, Marc-André Guerville et al. · Vaccine Open access Feb 2010 100
45 Is depression associated with health risk-related behaviour clusters in adults? P Verger, Caroline Lions, Bruno Ventelou · European Journal of Public Health Open access 29 Apr 2009 100
46 Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial Luis Sagaon‐Teyssier, Marie Suzan‐Monti, Baptiste Demoulin et al. · AIDS Care Open access 17 Feb 2016 96
47 Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study Aurélie Bocquier, Lisa Fressard, Sébastien Cortaredona et al. · Vaccine Open access 31 Oct 2018 92
48 Down syndrome time-clustering in January 1987 in Belarus: Link with the Chernobyl accident? I Zatsepin, Pierre Verger, Elisabeth Robert‐Gnansia et al. · Reproductive Toxicology 31 Jul 2007 92
49 Formal and informal care for disabled elderly living in the community: an appraisal of French care composition and costs Alain Paraponaris, Bérengère Davin, Pierre Verger · The European Journal of Health Economics 13 Mar 2011 91
50 Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey Céline Pulcini, Sophie Massin, Odile Launay et al. · Vaccine 25 Jun 2013 91

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.